OHSU

IRB #

IRB00010345

Title

Contrast Enhanced MRI of the Prostate

Principal Investigator

Xin Li

Study Purpose

The purpose of this study is to assess whether the new quantitative MRI method can discriminate between malignant and benign prostate tissue (diagnostic) and differentiate aggressive from indolent prostate cancer (disease monitoring and differentiation).

Medical Condition(s)

Abnormal findings on Digital Rectal Examination (DRE) or elevated Prostate-Specific Antigen (PSA) test.
Patients with known prostate cancer and choose radical prostatectomy as disease management.

Eligibility Criteria

For prostate cancer diagnosis: Any patient with abnormal findings on Digital Rectal Examination or with elevated PSA.
For prostate cancer aggressiveness monitoring: prostate cancer patient choosing radical prostatectomy.

Age Range

18 - 75

Healthy Volunteers Needed

No

Duration of Participation

The MRI scan time is about 60 minutes.

Minors Included

No

Contact

Mr. William Woodward (503) 418-1526.
Dr. Xin Li (503) 418-1533.

Sponsor

NIH-NCI.

Recruitment End

12/31/2017

Compensation Provided

No


Go Back